Orbax is a drug owned by INTERVET, INC. It is protected by 1 US drug patent filed in 2020. All patents have expired. Details of Orbax’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US6514492 | Active | |
Exclusivity Information
Orbax holds 1 exclusivity out of which 1 has expired. Details of Orbax's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Mar 25, 2010 |
About Orbax
Orbax is a drug
owned by INTERVET, INC.
Orbax uses
Orbifloxacin as the active
ingredient.
Active Ingredient:
Orbax uses
Orbifloxacin as the active ingredient.
Check out other Drugs and Companies using
Orbifloxacin ingredient.